Study provides new insights into the molecular causes of rare, fatal hereditary disease

A study entitled “IER3IP1-mutations cause microcephaly by selective inhibition of ER-Golgi transport”, now published in the open access journal “Cellular and Molecular Life Sciences”, provides new insights into the molecular causes of a rare and usually fatal hereditary disease called MEDS1.

Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies

Review outlines the impact of diabetes on skeletal muscle regeneration, highlighting the need for focused research and innovative therapies to tackle this growing health issue.

March 18, 2024

Many Patients Take to Online Forum to Vent About SSRIs

Discontinuation or dosage change of selective serotonin reuptake inhibitors (SSRIs) may be more common than one would think, according to a qualitative study of online

July 18, 2023

Pfizer receives EC approval for LITFULO to treat alopecia areata

The marketing authorisation allows Pfizer to sell LITFULO in all 27 EU member states, as well as in Norway, Liechtenstein and Iceland. Credit: Pfizer. Pfizer

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.